An Open Label Study to Assess the Effect of Euryco-10® Oral Dietary Supplement in Senior Men

Status unconfirmed

Conditions studied: Healthy Aging

In brief

To evaluate the effect and support the tolerance of orally ingested formulation containing Eurycoma longifolia dietary supplement (Euryco-10) on a cohort of senior men.

Key facts

Study ID

NCT04584918

Run by

Innovus Pharmaceuticals, Inc.

People needed

12

Starts

2020-10-01

Expected to finish

2021-01-01

Last updated by the study team

2020-10-14

Who can join

Age: 55 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male ≥ 55 years of age

You may not qualify if…

• Severe lower urinary tract symptoms.
• Current use of any herbal and/or nutritional supplements that can interfere with testosterone.
• A history of cancer except melanoma skin cancer.
• Currently receiving treatment with cancer chemotherapy or antiandrogens.
• Chronic use of systemic glucocorticoids (use within >14 days up to the 3months prior to screening); use of non-testosterone anabolic steroids within12 months prior to screening.
• History of frequent opioid use >1 time/week during any week within 30 days prior to screening.
• Have a history of known angina.
• Have a history of severe liver disease or clinical evidence of hepatic impairment at screening.
• Untreated severe obstructive sleep apnea.
• Allergies to any of the ingredients in Euryco-10® or BioPerine.
• Any condition which would interfere with the subject's ability to provide informed consent, to comply with study instructions, or which might confound the interpretation of the study results

Where it is running

• San Diego Sexual Medicine — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.